Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
P. falciparum growth and inhibition assays from US Patent US11903936: "Anti-malarial agents"
Assay data:12 Active, 12 Activity ≤ 1 µM, 12 Tested
SummaryRelated BioAssays by Target
DHODH Kinetic Analysis from US Patent US11903936: "Anti-malarial agents"
Assay data:13 Active, 13 Activity ≤ 1 µM, 13 Tested
Re-testing in dose-response curve in Dd2 pLDH assay, at 72h
Assay data:15 Active, 4 Activity ≤ 1 µM, 15 Tested
Summary
Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7
Assay data:2 Tested
Invivo antimalarial activity against Plasmodium berghei K173 infected in mouse assessed as chemo-supression percentage at 10 mg/kg, ip by giemsa staining based microscopic analysis relative to control
Assay data:1 Tested
Invivo antimalarial activity against Plasmodium berghei K173 infected in mouse assessed as chemo-supression percentage at 100 mg/kg, ip by giemsa staining based microscopic analysis relative to control
Invivo antimalarial activity against Plasmodium berghei K173 infected in mouse assessed as chemo-supression percentage at 50 mg/kg, ip by giemsa staining based microscopic analysis relative to control
Invivo antimalarial activity against Plasmodium berghei K173 infected in mouse assessed as reduction in parasitemia at 100 mg/kg, ip measured after 6 days by giemsa staining based microscopic analysis relative to control
Invivo antimalarial activity against Plasmodium berghei K173 infected in mouse assessed as reduction in parasitemia at 50 mg/kg, ip measured after 6 days by giemsa staining based microscopic analysis relative to control
Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 measured after 72 hrs by giemsa staining based analysis
Assay data:4 Active, 4 Tested
Antimalarial activity against plasmodium falciparum 3D7 assessed as bacterial growth inhibition
Assay data:4 Active, 4 Activity ≤ 1 µM, 4 Tested
Inhibition of plasmodium falciparum fabZ
Antimalarial activity against drug sensitive Plasmodium falciparum KI assessed as inhibition of parasite growth
Assay data:1 Active, 1 Tested
Antimalarial activity against drug sensitive Plasmodium falciparum NF54 assessed as inhibition of parasite growth
Antimalarial activity against chloroquine sensitive Plasmodium falciparum FCR-3 infected in mouse FM3A cells ssessed as reduction in parasite growth
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Antiplasmodial activity against Plasmodium falciparum D6 assessed as reduction in plasmodial growth after 48 hrs by fluorescence based analysis
Assay data:3 Tested
Antiplasmodial activity against Plasmodium falciparum W2 assessed as reduction in plasmodial growth after 48 hrs by fluorescence based analysis
Antiplasmodial activity against Plasmodium falciparum K1 assessed as reduction in parasitic growth by fluorescence based analysis
Antiplasmodial activity against Plasmodium falciparum K1 assessed as reduction in parasite growth by fluorescence based assay
In vivo antiplasmodial activity against Plasmodium falciparum infected in mouse model
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on